✦ LIBER ✦

Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast

✍ Scribed by Leopold G. Koss

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 32 KB
Volume: 33
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.20315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytological criteria for the diagnosis o

Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast

✍ Anna M. Bofin; Stian Lydersen; Bjørn M. Hagmar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

Invasive breast cancer following ductal

Invasive breast cancer following ductal and lobular carcinoma in situ of the breast

✍ Fabio Levi; Lalao Randimbison; Van-Cong Te; Carlo La Vecchia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 73 KB 👁 2 views

Immunohistochemical expression of E-cadh

Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast

✍ Gil Facina; Pedro Vitor Lopes-Costa; Alesse Ribeiro Dos Santos; Rodrigo Jose De 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

Aberrant expression of muc1 mucin in duc

Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast

✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought

Ductal carcinoma in situ of the male bre

Ductal carcinoma in situ of the male breast

✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Heterogeneity of ductal carcinoma in sit

Heterogeneity of ductal carcinoma in situ of the breast

✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents